Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Ionic pores formed by cyclic peptides.

F Heitz1, F Kaddari, N Van Mau

  • 1Laboratoire de Physico-Chimie des Systèmes Polyphasés, UA-330 du CNRS, Montpellier, France.

Biochimie
|January 1, 1989
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Durvalumab with carboplatin/paclitaxel and bevacizumab followed by durvalumab and bevacizumab with or without olaparib maintenance in newly diagnosed non-BRCA-mutated advanced ovarian cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Niraparib first-line maintenance therapy in patients with newly diagnosed advanced ovarian cancer: final overall survival results from the PRIMA/ENGOT-OV26/GOG-3012 trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2024
Same author

Maintenance olaparib rechallenge in patients with platinum-sensitive relapsed ovarian cancer previously treated with a PARP inhibitor (OReO/ENGOT-ov38): a phase IIIb trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2023
Same author

Association of location of BRCA1 and BRCA2 mutations with benefit from olaparib and bevacizumab maintenance in high-grade ovarian cancer: phase III PAOLA-1/ENGOT-ov25 trial subgroup exploratory analysis.

Annals of oncology : official journal of the European Society for Medical Oncology·2022
Same author

Depression and anxiety in women with malignant ovarian germ cell (MOGCT) and sex cord stromal tumors (SCST): an analysis of the AGO-CORSETT database.

Archives of gynecology and obstetrics·2022
Same author

Biocrust cover and successional stages influence soil bacterial composition and diversity in semiarid ecosystems.

The Science of the total environment·2020
Same journal

Differential cardiac microRNA expression in anoxic Trachemys scripta elegans turtles.

Biochimie·2026
Same journal

Renal failure-driven luminal ammonia production impairs gut barrier function in CKD.

Biochimie·2026
Same journal

Conditional Knockout of Indoleamine 2, 3-Dioxygenase-1 in Osteoprogenitor Cells in Mice Results in Sex-dependent Differences in Bone Mass.

Biochimie·2026
Same journal

Sedentariness disrupts, while exercise restores, thermogenic and metabolic plasticity in inguinal adipose tissue of mice.

Biochimie·2026
Same journal

Chrononutrition as a modulator of retinal metabolic resilience: A translational framework linking circadian biology to ocular disease.

Biochimie·2026
Same journal

Heterologous expression, purification, and biophysical characterisation of the cobalt-dependent nitrile hydratase from Rhodococcus rhodochrous ATCC BAA-870.

Biochimie·2026
See all related articles

Cyclic peptides like tentoxin and HC toxin form transmembrane ionic channels, challenging expectations based on their structure. This pore-forming ability extends to various cyclic peptides, suggesting aggregate-based pore structures.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Biophysics

Background:

  • Cyclic peptides often function as carriers due to their structure.
  • Tentoxin and HC toxin are cyclic tetrapeptides with specific chemical properties.
  • Transmembrane ionic channel formation is a known mechanism for peptide transport.

Purpose of the Study:

  • To investigate the ability of tentoxin and HC toxin to induce transmembrane ionic channels.
  • To explore the broader potential of cyclic peptides in forming ion channels.
  • To propose a structural model for peptide-induced pores.

Main Methods:

  • Electrophysiological measurements to detect ionic channel formation.
  • Analysis of cyclic peptide structure and its correlation with function.

Related Experiment Videos

  • Comparative studies with other cyclic peptides of varying sizes and sequences.

    • Main Results:

    • Tentoxin and HC toxin were found to induce transmembrane ionic channels.
    • This channel formation occurred despite structural features (proline, N-methylated residues) suggesting carrier mechanisms.
    • Larger cyclic peptides (tyrocidines, gramicidin S) and an HC toxin-like octapeptide also formed pores.
    • The findings suggest a generalizable pore-forming capability for cyclic peptides.

    Conclusions:

    • Cyclic peptides, including smaller ones like tentoxin and HC toxin, can form transmembrane ionic channels.
    • The ability to form pores is not limited by peptide size or specific structural motifs typically associated with carriers.
    • A model proposing aggregate-based pore structures is suggested for these cyclic peptides.